Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Tobin Juvenal sold 1,301 shares of Castle Biosciences stock in a transaction on Monday, November 24th. Castle Biosciences Trading Up 0.2%Castle Biosciences stock traded up $0.07 during trading on Thursday, hitting $30.47. Get Castle Biosciences alerts:Castle Biosciences (NASDAQ:CSTL – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. BTIG raises Castle Biosciences price targetThe higher target reflects confidence in Castle Biosciences’ molecular-diagnostics growth prospects and implies meaningful upside from recent trading levels. Featured StoriesReceive News & Ratings for Castle Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castle Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.